{"task_id": "c8c76f024d830a4d", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 873/905)", "text": "nosis-and-\nmanagement-of-barrett-s-oesophagus.html\n\n--- Page 879 ---\n865\nReferences\n10 Ambardekar AV, Krantz MJ. The Brugada syndrome: the perfect storm of genetics and environment? \nInt J Cardiol 2009; 141(1):108\u20139. https://www.ncbi.nlm.nih.gov/pubmed/19157599\n11 Hedley PL, J\u00f8rgensen P, Schlamowitz S, et al. The genetic basis of Brugada syndrome: a mutation \nupdate. Hum Mutat 2009; 30(9):1256\u201366. https://www.ncbi.nlm.nih.gov/pubmed/19606473\n12 Moon SJ, Lee JK, Kim TW, et al. Idiopathic transverse myelitis presenting as the Brown-S\u00e9quard syn-\ndrome. Spinal Cord 2008; 47(2):176\u20138. http://www.nature.com/sc/journal/v47/n2/full/sc200823a.html\n13 Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004; 350:578\u201385. http://www.\nnejm.org/doi/full/10.1056/NEJMra020282 \n14 Vaglio A, Moosig F, Zwerina J. Churg-Strauss syndrome: update on pathophysiology and treatment. \nCurr Opin Rheumatol 2012; 24(1):24\u201330. https://www.ncbi.nlm.nih.gov/pubmed/22089097\n15 Liberski PP, Sikorska B, Hauw JJ, et al. Tubulovesicular structures are a consistent (and unexplained) \n\ufb01 nding in the brains of humans with prion diseases. Virus Res 2008; 132(1\u20132):226\u20138. https://www.ncbi.nlm.\nnih.gov/pubmed/18164506\n16 CJD surveillance unit in Edinburgh. 2009. http://www.cjd.ed.ac.uk/documents/\ufb01 gs.pdf\n17 Dorsey K, Zou S, Schonberger LB, et al. Lack of evidence of transfusion transmission of Creutzfeldt-\nJakob disease in a US surveillance study. Transfusion 2009; 49(5):977\u201384. https://www.ncbi.nlm.nih.gov/\npubmed/19170987\n18 Iwasaki Y, Mimuro M, Yoshida M, et al. Clinical diagnosis of Creutzfeldt-Jakob disease: accuracy based \non analysis of autopsy-con\ufb01 rmed cases. J Neurol Sci 2008; 277(1\u20132):119\u201323. https://www.ncbi.nlm.nih.gov/\npubmed/19056094\n19 Armstrong RA. Creutzfeldt-Jakob disease and vision. Clin Exp Optom 2006; 89(1):3\u20139. https://www.ncbi.\nnlm.nih.gov/pubmed/16430434\n20 Zanusso G, Ferrari S, Cardone F, et al. Detection of pathologic prion protein in the olfactory epithelium in \nsporadic Creutzfeldt\u2013Jakob disease. N Engl J Med 2003; 348:711\u201319. http://www.nejm.org/doi/full/10.1056/\nNEJMoa022043#t=article\n21 Tatersall R, Turner B. Brown-S\u00e9quard and his syndrome. Lancet 2000; 356:61\u20133. http://www.thelancet.\ncom/journals/lancet/article/PIIS0140-6736(00)02441-7/abstract \n22 Goodall CA, Head MW, Everington D, et al. Raised CSF phospho-tau concentrations in variant \nCreutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 2006; \n77(1):89\u201391. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117383/\n23 Karazindiyanoglu S, Cayan S. The eff ect of testosterone therapy on lower urinary tract symptoms/blad-\nder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 2008; 11(3):146\u20139. \nhttps://www.ncbi.nlm.nih.gov/pubmed/18821291\n24 Studd J. A comparison of 19th century and current attitudes to female sexuality. Gynecol Endocrinol \n2007; 23(12):673\u201381. https://www.ncbi.nlm.nih.gov/pubmed/18075842\n25 Cussons AJ, Bhagat CI, Fletcher SJ, et al. Brown-S\u00e9quard revisited: a lesson from history on the pla-\ncebo eff ect of androgen treatment. Med J Aust 2002; 177(11\u201312):678\u20139. https://www.ncbi.nlm.nih.gov/pub-\nmed/12463999\n26 Bliss M. Harvey Cushing: A life in surgery. Toronto: University of Toronto Press, 2005\n27 Liberski PP, Brown P. Kuru: its rami\ufb01 cations after \ufb01 fty years. Exp Gerontol 2009; 44(1\u20132):63\u20139. https://\nwww.ncbi.nlm.nih.gov/pubmed/18606515\n28 Miller N. The misfolding diseases unfold. Beremans Limited. 2004 http://www.beremans.com/pdf/\nThe_misfolding_diseases_unfold.pdf\n29 Lepur D, Peterkovic\u00b4 V, Kalabric\u00b4-Lepur N. Neuromyelitis optica with CSF examination mimicking bacte-\nrial meningomyelitis. Neurol Sci 2009; 30(1):51\u20134. https://www.ncbi.nlm.nih.gov/pubmed/19145403\n30 Kim SH, Kim W, Li XF, et al. Repeated treatment with rituximab based on the assessment of peripheral \ncirculating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 2011; \n68(11):1412\u201320. http://jamanetwork.com/journals/jamaneurology/fullarticle/1107915\n31 Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339:1217\u201327. \nhttp://www.nejm.org/doi/full/10.1056/NEJM199810223391707\n32 Badalamente MA, Hurst LC. Effi  cacy and safety of injectable mixed collagenase subtypes in the treat-\nment of Dupuytren\u2019s contracture. J Hand Surg Am 2007; 32(6):767\u201374. https://www.ncbi.nlm.nih.gov/pub-\nmed/17606053\n33 Wetter TC. Restless legs syndrome: a review for the renal care professionals. EDTNA ERCA J 2001; \n27(1):42\u20136. https://www.ncbi.nlm.nih.gov/pubmed/12603074\n34 Schaefer RM, Tylki-Szymac\u00b4ska A, Hilz MJ. Enzyme replacement therapy for Fabry disease: a systematic \nreview of available evidence. Drugs 2009; 69(16):2179\u2013205. https://www.ncbi.nlm.nih.gov/pubmed/19852524\n35 Narv\u00e1ez J, Domingo-Domenech E, G\u00f3mez-Vaquero C, et al. Biological agents in the management of \nFelty\u2019s syndrome: a systematic review. Semin Arthritis Rheum 2012; 41(5):658\u201368. https://www.ncbi.nlm.\nnih.gov/pubmed/22119104\n36 Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet 2003; 361(9361):889\u201390. \nhttp://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)12784-5/abstract\n37 Losacco T, Punzo C, Santacroce L. [Gardner syndrome: clinical and epidemiologic up to date]. Clin Ter \n2005; 156(6):267\u201371. https://www.ncbi.nlm.nih.gov/pubmed/16463563\n38 Okai T, Yamaguchi Y, Sakai J, et al. Case report: complete regression of colonic adenomas after treat-\nment with sulindac in Gardner\u2019s syndrome: a 4-year follow-up. J Gastroenterol 2001; 36:778\u201382. https://\nwww.ncbi.nlm.nih.gov/pubmed/11757751 \n39 Mignot E. Narcolepsy and the HLA system. N Engl J Med 2001; 344:692. http://www.nejm.org/doi/\nfull/10.1056/NEJM200103013440918#t=article\n40 Freeman RD, Zinner SH, M\u00fcller-Vahl KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child \nNeurol 2009; 51(3):218\u201327. https://www.ncbi.nlm.nih.gov/pubmed/19183216\n41 Turtle L, Robertson MM. Tics, twitches, tales: the experiences of Gilles de la Tourette\u2019s syndrome. Am J \nOrthopsychiatry 2008; 78(4):449\u201355. https://www.ncbi.nlm.nih.gov/pubmed/19123766\n42 Himle MB, Woods DW, Piacentini JC, et al. Brief review of habit reversal training for Tourette syndrome. \nJ Child Neurol 2006; 21(8):719\u201325. https://www.ncbi.nlm.nih.gov/pubmed/16970874\n43 Hughes RA, Swan AV, Rapha\u00ebl JC, et al. Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic \nreview. Brain 2007; 130(Pt 9):2245\u201357. https://www.ncbi.nlm.nih.gov/pubmed/17337484\n44 Nagayama H, Katayama Y. Nippon Rinsho. [Apheresis therapy in Guillain-Barr\u00e9 syndrome]. Nihon \nRinsho 2008; 66(6):1195\u20139. https://www.ncbi.nlm.nih.gov/pubmed/18540370", "text_length": 6701, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 873/905)", "type": "chunk", "chunk_index": 872, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.691470", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.693116", "status": "complete", "chunks_added": 4}